AXOGEN ($AXGN) posted quarterly earnings results on Wednesday, October 29th. The company reported earnings of $0.12 per share, beating estimates of $0.07 by $0.05. The company also reported revenue of $60,080,000, beating estimates of $57,941,671 by $2,138,329.
You can see Quiver Quantitative's $AXGN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
AXOGEN Insider Trading Activity
AXOGEN insiders have traded $AXGN stock on the open market 17 times in the past 6 months. Of those trades, 0 have been purchases and 17 have been sales.
Here’s a breakdown of recent trading of $AXGN stock by insiders over the last 6 months:
- WILLIAM P. MR. BURKE has made 0 purchases and 7 sales selling 38,457 shares for an estimated $666,789.
- JOSEPH A. TYNDALL has made 0 purchases and 4 sales selling 49,518 shares for an estimated $542,760.
- GUIDO J NEELS sold 4,073 shares for an estimated $43,214
- AMY MCBRIDE WENDELL sold 4,073 shares for an estimated $43,214
- JOHN JOHNSON sold 4,073 shares for an estimated $43,214
- ALAN M LEVINE sold 4,073 shares for an estimated $43,214
- KATHY JOHNSON WEILER sold 4,073 shares for an estimated $43,214
- ERICK WAYNE DEVINNEY (Chief Innovation Officer) sold 1,137 shares for an estimated $18,521
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
AXOGEN Hedge Fund Activity
We have seen 87 institutional investors add shares of AXOGEN stock to their portfolio, and 83 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BALYASNY ASSET MANAGEMENT L.P. added 1,250,968 shares (+183.9%) to their portfolio in Q2 2025, for an estimated $13,573,002
- DRIEHAUS CAPITAL MANAGEMENT LLC removed 1,172,029 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $12,716,514
- WASATCH ADVISORS LP added 659,149 shares (+85.1%) to their portfolio in Q2 2025, for an estimated $7,151,766
- ARMISTICE CAPITAL, LLC added 573,041 shares (+106.5%) to their portfolio in Q2 2025, for an estimated $6,217,494
- NICHOLAS INVESTMENT PARTNERS, LP removed 414,281 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $4,494,948
- SQUAREPOINT OPS LLC added 348,950 shares (+259.2%) to their portfolio in Q2 2025, for an estimated $3,786,107
- INVESCO LTD. removed 334,046 shares (-87.3%) from their portfolio in Q2 2025, for an estimated $3,624,399
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
AXOGEN Analyst Ratings
Wall Street analysts have issued reports on $AXGN in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 09/30/2025
- Canaccord Genuity issued a "Buy" rating on 05/13/2025
To track analyst ratings and price targets for AXOGEN, check out Quiver Quantitative's $AXGN forecast page.
AXOGEN Price Targets
Multiple analysts have issued price targets for $AXGN recently. We have seen 2 analysts offer price targets for $AXGN in the last 6 months, with a median target of $24.5.
Here are some recent targets:
- Yi Chen from HC Wainwright & Co. set a target price of $25.0 on 09/30/2025
- Caitlin Cronin from Canaccord Genuity set a target price of $24.0 on 05/13/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
